Voyager Therapeutics and Neurocrine Biosciences announce selection of a lead gene therapy candidate for their FA program
On 26th February, the biotechnology company Voyager Therapeutics announced that as part of their collaboration with the biopharmaceutical company Neurocrine Biosciences, they have selected a lead development candidate in their […]
